GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Chenguang Biotech Group Co Ltd (SZSE:300138) » Definitions » Cash-to-Debt

Chenguang Biotech Group Co (SZSE:300138) Cash-to-Debt : 0.54 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Chenguang Biotech Group Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Chenguang Biotech Group Co's cash to debt ratio for the quarter that ended in Mar. 2025 was 0.54.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Chenguang Biotech Group Co couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2025.

The historical rank and industry rank for Chenguang Biotech Group Co's Cash-to-Debt or its related term are showing as below:

SZSE:300138' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.14   Med: 0.41   Max: 2.15
Current: 0.54

During the past 13 years, Chenguang Biotech Group Co's highest Cash to Debt Ratio was 2.15. The lowest was 0.14. And the median was 0.41.

SZSE:300138's Cash-to-Debt is ranked better than
50.53% of 1880 companies
in the Consumer Packaged Goods industry
Industry Median: 0.525 vs SZSE:300138: 0.54

Chenguang Biotech Group Co Cash-to-Debt Historical Data

The historical data trend for Chenguang Biotech Group Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Chenguang Biotech Group Co Cash-to-Debt Chart

Chenguang Biotech Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.30 0.41 0.36 0.37

Chenguang Biotech Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.58 0.63 0.37 0.54

Competitive Comparison of Chenguang Biotech Group Co's Cash-to-Debt

For the Farm Products subindustry, Chenguang Biotech Group Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chenguang Biotech Group Co's Cash-to-Debt Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Chenguang Biotech Group Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Chenguang Biotech Group Co's Cash-to-Debt falls into.


;
;

Chenguang Biotech Group Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Chenguang Biotech Group Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Chenguang Biotech Group Co's Cash to Debt Ratio for the quarter that ended in Mar. 2025 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chenguang Biotech Group Co  (SZSE:300138) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Chenguang Biotech Group Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Chenguang Biotech Group Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Chenguang Biotech Group Co Business Description

Traded in Other Exchanges
N/A
Address
Number 1 Chenguang Road, Hebei Province, Quzhou, CHN, 057250
Chenguang Biotech Group Co Ltd is engaged in the processing of agricultural products and herb extracts in China. Its products include natural colors, including paprika oleoresin, marigold oleoresin, curcumin, red rice red, red cabbage, and red beet; and natural spice extracts and essential oils, such as capsicum oleoresin, zanthoxylum oil and oleoresin, black pepper oil and oleoresin, ginger oil and oleoresin, turmeric oil, star anise oil and oleoresin, cumin oil and oleoresin, garlic oil and oleoresin, and common fennel oil and oleoresin.
Executives
Li Feng Fei Executives
Zhou Jing Directors, Directors, and Executives
Li Yue Zhai Director
Lian Yun He Executives
Chen Yun Xia Executives
Zhao Tao Supervisors
Yuan Xin Ying Supervisors
Liu Zhang Lin Independent director
Lu Qing Guo Directors, executives
Zhou Fang Sheng Independent director
Wang Shu Hong Independent director
Liu Ying Shan Director
Han Wen Jie Executives
Liu Dong Ming Supervisors
Yang Wen Fang Supervisors

Chenguang Biotech Group Co Headlines

No Headlines